Flagship Biosciences presents tissue-based IVDMIA development at the World Companion Diagnostics Summit
Flagstaff, AZ – December 6, 2010 – Flagship Biosciences LLC presents “Patient Stratification Using Digital Pathology Based Diagnostics” at the World Companion Diagnostics Summit in Boston, MA. Dr. Joseph Krueger, Co-Chairman of the Flagship Scientific Advisory Board presents a talk in the general session on the use of digital pathology for the development of single and multiplexed tissue-based companion diagnostics. This conference is an important collection of key thought leaders in the development of tissue-based companion diagnostics, including a special presention by an FDA official on the regulatory path for companion diagnostics approval.
Flagship Biosciences is a pathologist-owned company focused on utilizing whole slide imaging for quantitative pathology in pharmaceutical and device applications.
